Browsing Category
Pharma Industry News
4763 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Kiosk Operators expands in pharmaceutical kiosk space with Wellmation acquisition
Kiosk Operators LLC, a prominent provider of kiosk and locker solutions, has recently acquired Wellmation, a leader in…
BiVictriX Therapeutics receives FDA orphan drug designation for BVX001 in AML
BiVictriX Therapeutics plc (AIM: BVX), a prominent UK-based biotechnology firm, has reached a pivotal regulatory milestone as the…
Novartis announces promising long-term data on Kesimpta for relapsing multiple sclerosis
In a significant revelation, Novartis Pharmaceuticals Corporation has announced the latest findings from the ALITHIOS open-label extension study.…
GSK reveals significant Shingrix vaccine efficacy in ZOSTER-049 trial
GSK plc announced the results of the ZOSTER-049 phase III long-term follow-up trial, showcasing that the Shingrix (Recombinant…
Novartis reports significant proteinuria reduction by Fabhalta in Phase 3 IgAN trial
Novartis has shared encouraging results from the Phase III APPLAUSE-IgAN study, revealing that Fabhalta (iptacopan) led to a…
Biocon and Biomm ink exclusive deal to bring Semaglutide to Brazil
Biocon Limited (BSE code: 532523, NSE: BIOCON), a leader in global biopharmaceutical innovations, has announced a pivotal licensing…
FDA approves Alvotech and Teva Pharmaceuticals’ SELARSDI as biosimilar to Stelara
In a significant development in the pharmaceutical industry, Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of…
Novartis reveals significant results for Fabhalta in IgAN study at World Congress of Nephrology
Novartis has achieved a major milestone in the treatment of IgA nephropathy (IgAN), reporting a 38.3% reduction in…
Suven Life Sciences announces promising results at 76th American Academy of Neurology Meeting
Suven Life Sciences, a clinical-stage biopharmaceutical company focused on the development of novel treatments for Central Nervous System…
Diamyd Medical advances Diamyd with Phase 3 trial for Type 1 Diabetes
Diamyd Medical has achieved a significant milestone in its pioneering Phase 3 trial, DIAGNODE-3, of Diamyd in Type…